Literature DB >> 19896338

Collared mice: a model to assess the effects of scratching.

Satoshi Takeuchi1, Fumiko Yasukawa, Masutaka Furue, Stephen I Katz.   

Abstract

BACKGROUND: There is no current method to precisely assess pruritus despite its importance as a major symptom in many skin diseases. Pruritus induces scratching that worsens various inflammatory skin diseases.
OBJECTIVE: The purpose of this study was to determine the effects of scratching on allergic skin reactions using murine contact hypersensitivity (CH) as a model and to assess classical "anti-pruritic" agents using this model.
METHODS: We utilized plastic collars which were placed around the necks of mice to prevent them from scratching their ears during the development of CH. This allowed us to assess ear swelling as an index of CH, obviating the effects of scratching that occurs during the development of CH.
RESULTS: Following elicitation, the ear swelling of these "collared" mice was decreased by approximately 50%, compared to control mice in which collars were not used, suggesting that scratching contributes to the ear swelling that is measured as an index of CH. Using this model, we assessed the anti-pruritic effects of antihistamines, corticosteroids, non-steroidal antiinflammatory and sedative agents. All agents decreased CH when collars were not used. When collars were used, all agents, other than the sedatives, appeared to suppress CH, indicating their antiinflammatory effects. Sedative agents did not decrease CH in collared mice, indicating that their inhibitory effects in CH may be entirely due to their sedative effects.
CONCLUSIONS: This model enables the dissection of the various elements assessed when measuring CH in mice and may provide a simple tool to assess or screen potential anti-pruritic agents. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896338      PMCID: PMC2818307          DOI: 10.1016/j.jdermsci.2009.09.008

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  25 in total

1.  Evaluation of anti-scratch properties of oxatomide and epinastine in mice.

Authors:  N Inagaki; M Nagao; N Nakamura; H Kawasaki; K Igeta; K Musoh; H Nagai
Journal:  Eur J Pharmacol       Date:  2000-07-14       Impact factor: 4.432

Review 2.  Epidermal Langerhans cell migration and sensitisation to chemical allergens.

Authors:  Marie Cumberbatch; Rebecca J Dearman; Christopher E M Griffiths; Ian Kimber
Journal:  APMIS       Date:  2003 Jul-Aug       Impact factor: 3.205

3.  Prepubertal exposure to compounds that increase prolactin secretion in the male rat: effects on the adult prostate.

Authors:  T E Stoker; C L Robinette; B H Britt; S C Laws; R L Cooper
Journal:  Biol Reprod       Date:  1999-12       Impact factor: 4.285

4.  Itch-associated response induced by experimental dry skin in mice.

Authors:  Takayuki Miyamoto; Hiroshi Nojima; Tomoko Shinkado; Takashi Nakahashi; Yasushi Kuraishi
Journal:  Jpn J Pharmacol       Date:  2002-03

5.  Evaluation of antipruritic effects of several agents on scratching behavior by NC/Nga mice.

Authors:  Norikazu Takano; Iwao Arai; Yuki Hashimoto; Michio Kurachi
Journal:  Eur J Pharmacol       Date:  2004-07-14       Impact factor: 4.432

6.  Ultraviolet light exposure suppresses contact hypersensitivity by abrogating endothelial intercellular adhesion molecule-1 up-regulation at the elicitation site.

Authors:  Kazuhiro Komura; Minoru Hasegawa; Yasuhito Hamaguchi; Eriko Saito; Yuko Kaburagi; Koichi Yanaba; Shigeru Kawara; Kazuhiko Takehara; Makoto Seki; Douglas A Steeber; Thomas F Tedder; Shinichi Sato
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

7.  Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor.

Authors:  Cornelia Halin; Hermann Fahrngruber; Josef G Meingassner; Guido Bold; Amanda Littlewood-Evans; Anton Stuetz; Michael Detmar
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

8.  Increased E-selectin, IL-8 and IL-10 gene expression in human skin after minimal trauma.

Authors:  Fumiko Takeuchi; Robert D Sterilein; Russell P Hall
Journal:  Exp Dermatol       Date:  2003-12       Impact factor: 3.960

9.  A new analytical system for quantification scratching behaviour in mice.

Authors:  K Orito; Y Chida; C Fujisawa; P D Arkwright; H Matsuda
Journal:  Br J Dermatol       Date:  2004-01       Impact factor: 9.302

10.  Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.

Authors:  M Kawashima; T Tango; T Noguchi; M Inagi; H Nakagawa; S Harada
Journal:  Br J Dermatol       Date:  2003-06       Impact factor: 9.302

View more
  4 in total

Review 1.  Interleukin-31 and Pruritic Skin.

Authors:  Masutaka Furue; Mihoko Furue
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

2.  Tremella fuciformis polysaccharides alleviate induced atopic dermatitis in mice by regulating immune response and gut microbiota.

Authors:  Lingna Xie; Kaiye Yang; Yiheng Liang; Zhenyuan Zhu; Zhengqiang Yuan; Zhiyun Du
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

3.  A randomized, open-label, multicenter trial of topical tacrolimus for the treatment of pruritis in patients with atopic dermatitis.

Authors:  Satoshi Takeuchi; Hidehisa Saeki; Shoji Tokunaga; Makoto Sugaya; Hanako Ohmatsu; Yuichiro Tsunemi; Hideshi Torii; Koichiro Nakamura; Tamihiro Kawakami; Yoshinao Soma; Eiichi Gyotoku; Michihiro Hide; Rikako Sasaki; Yukihiro Ohya; Makiko Kido; Masutaka Furue
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

4.  Lactobacillus paracasei KBL382 administration attenuates atopic dermatitis by modulating immune response and gut microbiota.

Authors:  Woon-Ki Kim; You Jin Jang; Dae Hee Han; Kyungchan Jeon; Cheonghoon Lee; Hyuk Seung Han; GwangPyo Ko
Journal:  Gut Microbes       Date:  2020-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.